PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) | MicrobiomeTrials← Back to trialsNCT07169630
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-11-01Est. Completion: 2029-04-11
Enrollment target: 90 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Aging
Background:
Some people experience cognitive decline as they age. That is, they lose memory, problem-solving, and other…
Baltimore, United StatesEst. completion Dec 12, 2029
Alzheimer's Disease
Background:
Normal aging, as well as dementias such as Alzheimer s disease, can cause changes in the brain that affect …
Baltimore, United StatesEst. completion Dec 31, 2030